Hb O-TIBESTI [β121(GH4)Glu → Lys; β11(A8)Val → Ile], A HEMOGLOBIN VARIANT CARRYING IN THE SAME β CHAIN THE SUBSTITUTIONS OF Hb O-ARAB AND Hb HAMILTON, FOUND IN COMBINATION WITH Hb S [β6(A3)Glu → Val]

Hemoglobin ◽  
2002 ◽  
Vol 26 (1) ◽  
pp. 13-20 ◽  
Author(s):  
Claude Préhu ◽  
Jean Riou ◽  
Isabelle Sartelet ◽  
Danielle Promé ◽  
Catherine Claparols ◽  
...  
Keyword(s):  
Hb S ◽  
Blood ◽  
1998 ◽  
Vol 91 (4) ◽  
pp. 1438-1445 ◽  
Author(s):  
Kazuhiko Adachi ◽  
Takamasa Yamaguchi ◽  
Jian Pang ◽  
Saul Surrey

Abstract Studies on assembly in vitro of α-globin chains with recombinant β16 Gly→Asp, β95 Lys→Glu, β120 Lys→Glu and β16 Gly→Asp, 120 Lys→Glu human β-globin chain variants in addition to human βA- and βS-globin chains were performed to evaluate effects of increased anionic charge in the β chain on hemoglobin assembly using soluble recombinant β-globin chains expressed in bacteria. A β112 Cys→Asp change was also engineered to monitor effects on assembly of increased negative charge at α1β1 interaction sites. Order of tetramer formation in vitro under limiting α-globin chain conditions showed Hb βG16D, K120E = Hb βK120E = Hb βK95E > Hb βG16D > Hb A > Hb S >>> Hb βC112D. In addition, β112 Cys→Asp chains exist as monomers rather than β4tetramers in the absence of α chains, and the β chain in Hb βC112D tetramers was readily exchanged by addition of βs. These results suggest that affinity between α and β chains is promoted by negatively-charged β chains up to a maximum of two additional net negative charges and is independent of location on the surface except at the α1β1 interaction site. In addition, our findings show that β112 Cys on the G helix is critical for facilitating formation of stable αβ dimers, which then form functional hemoglobin tetramers, and that β112 Cys→Asp inhibits formation of stable α1β1 and β1β2 interactions in α2β2 and β4 tetramers, respectively.


Hemoglobin ◽  
2009 ◽  
Vol 33 (1) ◽  
pp. 51-53
Author(s):  
John S. Waye ◽  
Lynda Walker ◽  
Lisa M. Nakamura ◽  
Barry Eng ◽  
Andrew McFarlane
Keyword(s):  

Hemoglobin ◽  
1989 ◽  
Vol 13 (5) ◽  
pp. 437-453 ◽  
Author(s):  
A. T. Gilbert ◽  
P. J. Fleming ◽  
D. R. Sumner ◽  
W. G. Hughes ◽  
R. A. B. Holland ◽  
...  

Hemoglobin ◽  
1995 ◽  
Vol 19 (1) ◽  
pp. 27-32
Author(s):  
D. Williamson ◽  
D. J. Perry ◽  
K. Brown ◽  
J. V. Langdown ◽  
C. de Silva

Blood ◽  
1964 ◽  
Vol 23 (2) ◽  
pp. 206-215 ◽  
Author(s):  
REGINALD P. PUGH ◽  
THOMAS V. MONICAL ◽  
VIRGINIA MINNICH

Abstract Hemoglobin studies have been presented on a patient with clinically typical sickle cell anemia who was found to possess two major adult hemoglobins, Hb S and hybrid Hb GPhil./S. Four hemoglobins were demonstrated in his mother, Hb A, GPhil., S and GPhil./S, in somewhat unexpected and as yet unexplained proportions. To our knowledge the propositus represents the first description of an individual with a homozygous β chain defect accompanied by a heterozygous α chain abnormality.


Hemoglobin ◽  
1978 ◽  
Vol 2 (5) ◽  
pp. 403-415 ◽  
Author(s):  
Junius G. Adams ◽  
Kenneth P. Przywara ◽  
Paul Heller ◽  
Mir Shamsuddin

Hemoglobin ◽  
1988 ◽  
Vol 12 (2) ◽  
pp. 149-161 ◽  
Author(s):  
A. T. Gilbert ◽  
P. J. Fleming ◽  
D. R. Sumner ◽  
W. G. Hughes ◽  
F. Ip ◽  
...  
Keyword(s):  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 3849-3849
Author(s):  
Ferdane Kutlar ◽  
Mary Ann Knovich ◽  
Dedrey Elam ◽  
Daniel B. Jobe ◽  
David H. Buss ◽  
...  

Abstract The co-existence of Hemoglobin H (Hb H) disease and heterozygosity for β-chain structural variants is a rare occurrence. Hb H disease has been reported in conjunction with Hb E, Hb C, Hb S, and Hb Hamilton. The combination of Hb H disease with Hb C and Hb S reportedly results in a mild hemolytic anemia without detectable Hb H. We present a new case of atypical Hb H disease that was also heterozygous for the rare β-chain variant Hb Raleigh. The patient is a 27-year-old Cambodian female referred for the evaluation of microcytic anemia unresponsive to iron. She had a lifelong history of generalized fatigue, exertional dyspnea, and weakness in her legs. Physical exam was unremarkable except for pallor of mucuous membranes. There was no hepatosplenomegaly. She had a Hb of 9.7, HCT 30.8, MCV 56, MCH 17.6, MCHC 31.5, ferritin 92. Hb analysis on IEF revealed Hb A, Hb A2, and an abnormal band slightly more anodic to Hb A. No Hb H was observed. On cation exchange HPLC, she had 49.7% Hb A, 48.1% Hb X, and 2.2% Hb A2. Reverse phase HPLC revealed a βx chain eluting immediately before βA. Oxygen affinity was slightly reduced. PCR amplification and sequencing of the β-globin gene revealed heterozygosity for Hb Raleigh (Exon 1, codon 1, GTG→GCG, VAL→ALA). The patient was also found to be a compound heterozygote for -α3.7 and --SEA deletions. This case represents a novel interaction of a structural β-chain variant with Hb H disease. Hb Raleigh has previously been reported in Caucasians and in two Swedish families. It has decreased oxygen affinity. This is the first report of this variant in a Cambodian population. The absence of any detectable Hb H likely results from the inability of variant β-chains to form a viable tetramer with a resultant decrease in βA. The low oxygen affinity did not negatively impact on the degree of anemia. This case, like some others reported previously, shows that the accurate diagnosis of Hb H disease in association with structural β-chain variants can be established by molecular methods, and the detection of Hb H on electrophoretic and chromatographic analyses may not always be reliable.


Sign in / Sign up

Export Citation Format

Share Document